Trials / Unknown
UnknownNCT04917289
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
Circulating Tumor Cell vs. Radiography as the Evidence of Disease Recurrence in Colorectal Cancer Patients Whose Tumor Underwent R0 Resection
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study enrolled patients who underwent R0 resection of tumor and had elevated tumor biomarkers (CEA, CA19-9). After enroll the study, a CTC test will performed and patients who had positive CTC will be randomly assigned to two groups. The control group will continue follow-up until radiological recurrence appear, the treatment group will start treatment or change the current adjuvant regimen. First endpoint is OS. The secondary endpoint is DFS, adverse event.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chemotherapy | Started chemotherapy or change the current adjuvant therapy |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2023-12-01
- Completion
- 2025-12-01
- First posted
- 2021-06-08
- Last updated
- 2021-06-08
Source: ClinicalTrials.gov record NCT04917289. Inclusion in this directory is not an endorsement.